Failure of SGLT-2 inhibitor in the context of new ileal conduit formation

被引:0
|
作者
Almog, Joel [1 ,4 ]
Jain, Shalu [2 ]
Pybass, Phillip [3 ]
Gupta, Ankur [1 ]
机构
[1] Te Whatu Ora Hlth New Zealand Midcent Dist, Dept Nephrol, Hamilton, New Zealand
[2] Te Whatu Ora Hlth New Zealand Midcent Dist, Diabet & Endocrinol Serv, Hamilton, New Zealand
[3] Te Whatu Ora Hlth New Zealand Midcent Dist, Dept Internal Med, Hamilton, New Zealand
[4] Palmerston North Hosp, Ground Floor,50 Ruahine St, Palmerston North 4442, New Zealand
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:83 / 85
页数:3
相关论文
共 50 条
  • [1] Acute Renal Failure With Cocaine and SGLT-2 Inhibitor
    Shrivastava, Snehal
    Srivastava, Nishit
    Alfanso-Jaume, Maria
    AMERICAN JOURNAL OF THERAPEUTICS, 2019, 26 (06) : E762 - E763
  • [2] SGLT-2 Inhibitor Use in Heart Failure A Review for Nurses
    March, Katherine L.
    Lukas, Jack G.
    Berei, Theodore J.
    Shah, Samarth P.
    Cave, Brandon E.
    CRITICAL CARE NURSING QUARTERLY, 2022, 45 (02) : 189 - 198
  • [3] SGLT-2 inhibitors in heart failure: a new therapeutic avenue
    Muthiah Vaduganathan
    Javed Butler
    Nature Medicine, 2019, 25 : 1653 - 1654
  • [4] POSTOPERATIVE EUGLYCEMIC KETOACIDOSIS IN THE SETTING OF SGLT-2 INHIBITOR USE FOR HEART FAILURE
    Sun, Herie
    Paul, Jonathan
    Miller, Lydia
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 98 - 98
  • [5] SHOULD CARDIOLOGIST PRESCRIBE AN SGLT-2 INHIBITOR?
    Jame, Sina
    Jame, Mary E.
    McMahon, Laurence
    Oral, Elif
    Hagan, Peter
    Rubenfire, Melvyn
    Weinberg, Richard
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1752 - 1752
  • [6] Remogliflozin: the new low cost SGLT-2 inhibitor for type 2 diabetes mellitus
    Atal, Shubham
    Fatima, Zeenat
    Singh, Sakshi
    Balakrishnan, Sadasivam
    Joshi, Rajnish
    DIABETOLOGY INTERNATIONAL, 2021, 12 (03) : 247 - 253
  • [7] Research on the efficacy of the new dual SGLT-1/SGLT-2 inhibitor HEC82375
    Wu, Wuyong
    Gu, Zheng
    Qin, Haoxiong
    Kang, Panpan
    Zhang, Lei
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2018, 34
  • [8] Remogliflozin: the new low cost SGLT-2 inhibitor for type 2 diabetes mellitus
    Shubham Atal
    Zeenat Fatima
    Sakshi Singh
    Sadasivam Balakrishnan
    Rajnish Joshi
    Diabetology International, 2021, 12 : 247 - 253
  • [9] Research progress on synthesis of SGLT-2 inhibitor ertugliflozin
    Hu, Xiaojie
    Wang, Yue
    Wang, Jicun
    Zheng, Lu
    Wu, Qingkun
    SYNTHETIC COMMUNICATIONS, 2025,
  • [10] Rare Infection Linked With SGLT-2 Inhibitor Use
    Voelker, Rebecca
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (13): : 1309 - 1309